ZIMMER BIOMET HOLDINGS, INC.
For the period ended Mar 31, 2026. Filed May 1, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 1, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes repurchases of common stock settled during the three-month period ended March 31, 2026:
| Period · Total Number of Shares Purchased · Average Price Paid per Share · Total Number of Shares Purchased as a Part of Publicly Announced Program(1) · Maximum Approximate Dollar Value of Shares that may yet bePurchased Under the Program(1) | |||||
|---|---|---|---|---|---|
| January 1-31, 2026 | - | $ | - | - | $1,500,000,000 |
| February 1-28, 2026 | 1,100,000 | 98.56 | 1,100,000 | 1,391,587,220 | |
| March 1-31, 2026 | 1,517,159 | 93.32 | 1,517,159 | 1,250,000,030 | |
| Total | 2,617,159 | $95.52 | 2,617,159 | $1,250,000,030 | |
(1) In February 2026, our Board of Directors authorized a $1.5 billion share repurchase program with no expiration date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.